Kyverna is leading other companies in the CAR-T sector. Their flagship product is KYV-101. It takes cells from the patient and engineers them with CD28 stimulation. Kyverna’s KYSA-8 delivered data on ...

Lyell Immunopharma, Inc. ( LYEL) TD Cowen 46th Annual Health Care Conference March 2, 2026 9:10 AM EST ...

Once the active ingredient is defined, an Applicant must select which patent, or patents, to put forward for extension. The statute permits only one PTE per regulatory review period, so the choice is ...

Moby summary of Ocugen, Inc.'s Q4 2025 earnings call ...

On track to file IND and/or CTA for Wilson Disease and AATD programs in 1H 2026 and mid-2026, respectively; initial clinical data for both ...

Late-breaking oral presentation to feature primary analysis from KYSA-8 registrational trial in stiff person syndrome (SPS)Oral presentation on ...

February 2026 proved to be a pivotal month for the oncology landscape, as the FDA green-lit several therapies targeting some of the most challenging diagnoses in modern medicine. From the introduction ...

On track to file IND and/or CTA for Wilson Disease and AATD programs in 1H 2026 and mid-2026, respectively; initial clinical data for both expected in 2027 -- -- Ongoing engagement with FDA for PM359 ...

AxoGen (NASDAQ:AXGN) used its presentation at the 47th annual Raymond James Institutional Investors Conference to outline its mission to make restoration of peripheral nerve function an expected ...

Tensions continue to escalate in Iran with Khamenei's funeral has been postponed, while Israel threatened his successor and 101 reported missing in at.

Kolkata: CM Mamata Banerjee is set to take to the streets again to protest the mass \"deletion of voters\" following the Special Intensive Revision (SIR.

Dharampal Singh reviewed organisational activities in separate meetings with the district in-charges of all 16 districts falling under the Kashi region, and all the Mandal Presidents of BLA-1 Varanasi ...